These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 22120546)

  • 1. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo intra-luteal implants of prostaglandin (PG) E(1) or E(2) (PGE(1), PGE(2)) prevent luteolysis in cows. I. Luteal weight, circulating progesterone, mRNA for luteal luteinizing hormone (LH) receptor, and occupied and unoccupied luteal receptors for LH.
    Weems YS; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Bridges PJ; Welsh TH; Lewis AW; Neuendorff DA; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):35-44. PubMed ID: 21601649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 (PGE1), but not prostaglandin E2 (PGE2), alters luteal and endometrial luteinizing hormone (LH) occupied and unoccupied LH receptors and mRNA for LH receptors in ovine luteal tissue to prevent luteolysis.
    Weems YS; Nett TM; Rispoli LA; Davis TL; Johnson DL; Uchima T; Raney A; Lennon E; Pang J; Harbert T; Bowers G; Goto K; Ong A; Tsutahara N; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):42-50. PubMed ID: 20060488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intraluteal implants of prostaglandin E1 or E2 on angiogenic growth factors in luteal tissue of Angus and Brahman cows.
    Weems YS; Ma Y; Ford SP; Nett TM; Vann RC; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Theriogenology; 2014 Dec; 82(9):1224-30. PubMed ID: 25219846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin E and F receptor agonists in vivo on luteal function in ewes.
    Weems YS; Nett TM; Rispoli LA; Davis TL; Johnson DL; Uchima T; Raney A; Lennon E; Harbert T; Bowers G; Tsutahara N; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):67-72. PubMed ID: 20381634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of LPA2R, LPA3R, or EP4R agonists on luteal or endometrial function in vivo or in vitro and sirtuin or EP1R, EP2R, EP3R or EP4R agonists on endometrial secretion of PGE and PGF
    LaPorte ME; Weems YS; Arreguin-Arevalo A; Nett TM; Tsutahara N; Sy T; Haberman J; Chon M; Randel RD; Weems CW
    Theriogenology; 2017 Jun; 95():8-17. PubMed ID: 28460684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes.
    Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is endothelin-1 luteolytic or antiluteolytic in ewes?
    Weems YS; Johnson D; Uchima T; Raney A; Lennon E; Goto K; Bowers G; Saldana J; Pang J; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2009 Dec; 90(3-4):63-8. PubMed ID: 19723588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism whereby nitric oxide (NO) infused chronically intrauterine in ewes is antiluteolytic rather than being luteolytic.
    Weems YS; Lennon E; Uchima T; Raney A; Goto K; Ong A; Zaleski H; Weems CW
    Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):33-41. PubMed ID: 18078774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 or E2 inhibits an oxytocin-induced premature luteolysis in ewes when oxytocin is given early in the estrous cycle.
    Weems YS; Pang J; Raney A; Uchima T; Lennon E; Johnson D; Nett TM; Randel RD; Weems CW
    Theriogenology; 2014 Aug; 82(3):440-6. PubMed ID: 24908337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of luteolytic capacity involves differential regulation by prostaglandin F2alpha of genes involved in progesterone biosynthesis in the porcine corpus luteum.
    Diaz FJ; Wiltbank MC
    Domest Anim Endocrinol; 2005 Feb; 28(2):172-89. PubMed ID: 15713365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 or E2 (PGE1, PGE2) prevents premature luteolysis induced by progesterone given early in the estrous cycle in ewes.
    Weems YS; Raney A; Pang J; Uchima T; Lennon E; Johnson D; Nett TM; Randel RD; Weems CW
    Theriogenology; 2013 Sep; 80(5):507-12. PubMed ID: 23800694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
    Walch L; Clavarino E; Morris PL
    Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of luteinizing hormone (LH), pregnancy-specific protein B (PSPB), or arachidonic acid (AA) on secretion of progesterone and prostaglandins (PG) E (PGE; PGE(1) and PGE(2)) and F(2alpha) (PGF(2alpha)) by ovine corpora lutea of the estrous cycle or pregnancy in vitro.
    Weems YS; Kim L; Humphreys V; Tsuda V; Blankfein R; Wong A; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Nov; 84(3-4):163-73. PubMed ID: 17991618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons.
    Southall MD; Vasko MR
    J Biol Chem; 2001 May; 276(19):16083-91. PubMed ID: 11278900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
    Ueta M; Matsuoka T; Sotozono C; Kinoshita S
    Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.